• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2031

    11/17/25 8:20:00 AM ET
    $MOH
    Medical Specialities
    Health Care
    Get the next $MOH alert in real time by email

    Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced that it intends to privately offer, subject to market and other conditions, $750 million aggregate principal amount of senior notes due 2031 (the "Notes"). The Company will make the offering pursuant to an exemption under the Securities Act of 1933, as amended (the "Securities Act"). The initial purchasers will offer the Notes only to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act and to certain non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act ("Regulation S").

    The Notes will not be guaranteed by any of the Company's subsidiaries at the time of issuance. The interest rate, offering price and other terms of the Notes will be determined by negotiations between the Company and the representative of the initial purchasers. The issuance of the Notes will be subject to customary closing conditions.

    The Company intends to use the net proceeds from the offering to repay the Company's outstanding delayed draw term loans under its existing credit agreement.

    The Notes have not been and will not be registered under the Securities Act or any state securities laws and may not be offered or sold within the United States or to, or for the benefit of, a U.S. person (as defined in Regulation S) except in transactions exempt from, or not subject to, the registration requirements of the Securities Act.

    This press release shall not constitute an offer to sell or a solicitation of an offer to purchase the Notes and shall not constitute an offer, solicitation or sale in any state or jurisdiction where such offer, solicitation or sale is prohibited.

    About Molina Healthcare

    Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit molinahealthcare.com.

    Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

    This press release contains forward-looking statements. The Company intends such forward-looking statements to be covered under the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements provide current expectations of future events based on certain assumptions, and all statements other than statements of historical fact contained in this press release may be forward-looking statements. In some cases, you can identify forward-looking statements by words such as "intends," "will," "may," or the negative of these terms or other similar expressions. Forward-looking statements contained in this press release include, but are not limited to, statements related to the Company's offering of the Notes and the intended use of net proceeds of the offering, which are subject to risks and uncertainties, including, without limitation, risks related to whether the Company will consummate the offering of the Notes on the expected terms, or at all, market and other general economic conditions, and whether the Company will be able to satisfy the conditions required to close any sale of the Notes. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or events projected or contemplated by its forward-looking statements will in fact occur, and it cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company's judgment as of the date hereof, and, except as otherwise required by law, the Company disclaims any obligation to update any forward‑looking statements to conform the statement to actual results or changes in its expectations.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251116100478/en/

    Investor Contact: Jeff Geyer, [email protected], 305-317-3012

    Media Contact: Caroline Zubieta, [email protected], 562-951-1588

    Get the next $MOH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MOH

    DatePrice TargetRatingAnalyst
    10/24/2025$144.00Equal Weight → Underweight
    Barclays
    10/16/2025$203.00Buy → Hold
    TD Cowen
    10/14/2025$207.00Neutral
    Goldman
    7/25/2025$210.00Overweight → Neutral
    Cantor Fitzgerald
    7/25/2025$180.00Buy → Hold
    Truist
    7/10/2025$266.00Overweight → Equal-Weight
    Morgan Stanley
    6/9/2025$364.00Overweight
    Morgan Stanley
    4/22/2025$414.00Outperform
    Bernstein
    More analyst ratings

    $MOH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Woys James bought $1,559,365 worth of shares (10,000 units at $155.94), increasing direct ownership by 16% to 74,331 units (SEC Form 4)

    4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

    8/6/25 4:47:39 PM ET
    $MOH
    Medical Specialities
    Health Care

    $MOH
    SEC Filings

    View All

    Molina Healthcare Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

    11/20/25 4:27:59 PM ET
    $MOH
    Medical Specialities
    Health Care

    Molina Healthcare Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

    11/17/25 8:25:40 AM ET
    $MOH
    Medical Specialities
    Health Care

    Molina Healthcare Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

    11/14/25 4:15:54 PM ET
    $MOH
    Medical Specialities
    Health Care

    $MOH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Molina Healthcare downgraded by Barclays with a new price target

    Barclays downgraded Molina Healthcare from Equal Weight to Underweight and set a new price target of $144.00

    10/24/25 8:58:34 AM ET
    $MOH
    Medical Specialities
    Health Care

    Molina Healthcare downgraded by TD Cowen with a new price target

    TD Cowen downgraded Molina Healthcare from Buy to Hold and set a new price target of $203.00

    10/16/25 8:20:06 AM ET
    $MOH
    Medical Specialities
    Health Care

    Goldman initiated coverage on Molina Healthcare with a new price target

    Goldman initiated coverage of Molina Healthcare with a rating of Neutral and set a new price target of $207.00

    10/14/25 8:50:43 AM ET
    $MOH
    Medical Specialities
    Health Care

    $MOH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Schapiro Richard M sold $51,058 worth of shares (357 units at $143.02), decreasing direct ownership by 3% to 11,352 units (SEC Form 4)

    4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

    11/24/25 4:35:18 PM ET
    $MOH
    Medical Specialities
    Health Care

    Director Zoretic Richard C was granted 285 shares (SEC Form 4)

    4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

    10/2/25 8:08:55 PM ET
    $MOH
    Medical Specialities
    Health Care

    Director Wolf Dale B was granted 285 shares (SEC Form 4)

    4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

    10/2/25 8:08:03 PM ET
    $MOH
    Medical Specialities
    Health Care

    $MOH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Molina Healthcare Announces Closing of Offering of $850 Million of 6.500% Senior Notes Due 2031

    Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced the closing of its previously announced offering of $850 million aggregate principal amount of 6.500% senior notes due 2031 (the "Notes") sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The Notes bear interest at a rate of 6.500% per annum. Interest on the Notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing August 15, 2026 and a

    11/20/25 4:15:00 PM ET
    $MOH
    Medical Specialities
    Health Care

    Molina Healthcare Announces Pricing of $850 Million of 6.500% Senior Notes Due 2031

    Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced that it priced $850 million aggregate principal amount of its 6.500% senior notes due 2031 (the "Notes") to be sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The offering is expected to close on or about November 20, 2025 (such actual closing date, the "Settlement Date"), subject to the satisfaction of customary closing conditions. The Notes will not be guaranteed by any

    11/17/25 6:10:00 PM ET
    $MOH
    Medical Specialities
    Health Care

    Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2031

    Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced that it intends to privately offer, subject to market and other conditions, $750 million aggregate principal amount of senior notes due 2031 (the "Notes"). The Company will make the offering pursuant to an exemption under the Securities Act of 1933, as amended (the "Securities Act"). The initial purchasers will offer the Notes only to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act and to certain non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act ("Regulation S"). The Notes will not be guaranteed by any of the Com

    11/17/25 8:20:00 AM ET
    $MOH
    Medical Specialities
    Health Care

    $MOH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Molina Healthcare Inc

    SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

    11/14/24 1:22:34 PM ET
    $MOH
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Molina Healthcare Inc

    SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

    11/12/24 12:53:29 PM ET
    $MOH
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Molina Healthcare Inc

    SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

    11/8/24 10:34:33 AM ET
    $MOH
    Medical Specialities
    Health Care

    $MOH
    Financials

    Live finance-specific insights

    View All

    Molina Healthcare Reports Third Quarter 2025 Financial Results

    Revises Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported third quarter 2025 GAAP earnings per diluted share of $1.51 and adjusted earnings per diluted share of $1.84. Financial results are summarized below:   Three months ended   Nine months ended   September 30,   September 30,   2025   2024   2025   2024                 (In millions, except per-share results) Premium Revenue $ 10,841     $ 9,694     $ 32,337    

    10/22/25 4:15:00 PM ET
    $MOH
    Medical Specialities
    Health Care

    Molina Healthcare Announces Third Quarter 2025 Earnings Release and Conference Call Dates

    Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the third quarter ending September 30, 2025, after the market closes on Wednesday, October 22, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, October 23, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 2660919. A telephonic replay of the conference call will be available through Thursday, October 30, 2025, by dialing (877) 344-7529 and entering the confirmation number, 1905016. A live broadcast of Molina Healthcare's conference call will be available on the Company's inve

    9/3/25 9:00:00 AM ET
    $MOH
    Medical Specialities
    Health Care

    Molina Healthcare Reports Second Quarter 2025 Financial Results

    Revises Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2025 GAAP earnings per diluted share of $4.75 and adjusted earnings per diluted share of $5.48. Financial results are summarized below:   Three months ended   Six months ended   June 30,   June 30,   2025   2024   2025   2024                 (In millions, except per-share results) Premium Revenue $10,868   $9,446   $21,496   $18,950 Total Revenue $11,427  

    7/23/25 4:15:00 PM ET
    $MOH
    Medical Specialities
    Health Care